Clinical Trial Update: A Study to Assess the Safety, Tolerability and Potential Efficacy of a Tracheal Replacement Consisting of a Tissue-engineered Tracheal Scaffold With Seeded Mesenchymal Cells [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating a tissue-engineered tracheal scaffold with seeded mesenchymal cells to treat tracheomalacia and tracheal stenosis has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tracheal Stenosis
• Tracheomalacia

Snippet

Sponsor: Cell Therapy Catapult | Conditions: Tracheomalacia, Tracheal Stenosis | Phase 1 | Status: SUSPENDED